請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/22706
標題: | 台灣中草藥取得美國 FDA植物藥品許可之研究:產業群聚觀點 Taiwan’s Traditional Chinese Medicine to US FDA Botanical Drugs: A Cluster Perspective |
作者: | Chris H. Lee 李玄曲 |
指導教授: | 陳鴻基(Houn-Gee Chen) |
關鍵字: | 群聚,台灣,中草藥,植物,藥品,許可, Traditional Chinese Medicine,World Health Organization,Botanical,US FDA,CMO,CRO,Clusters, |
出版年 : | 2010 |
學位: | 碩士 |
摘要: | Taiwan has many core competences in the TCM industry. Amongst the more tangible ones include clinical centers and an official committee to regulate TCM established since 1995. The intangible and equally valuable are the R&D talents, laws in favor of proprietary protection of firms, and reputation that’s developed over decades of manufacturing “Taiwan” branded quality products. By banking on these assets, Taiwan may be in a key position to develop a pipeline of botanical drugs to apply to the US FDA.
In so forth, this research demonstrates that Taiwan’s TCM industry can benefit from business clusters based on Professor Michael Porter’s argument in The Competitive Advantage of Nations, 1990, where he modeled the effect of the local business environment on competition in terms of four interrelated influences depicted as the Diamond Theory. Through his studies of the California Wine Industry, there are similarities in the vertical supply chain of the industry to that of the TCM industry, both originating from the agricultural sector. Thus it is pertinent to explore and learn from successful cases and how it may be fruitful for Taiwan’s TCM industry. In his literature, a business cluster is a geographical location where enough resources and competences are amassed and an industry has reached a critical threshold, giving it a key position in a given economic branch of activity, with a decisive sustainable competitive advantage over other places, or even world supremacy in that field . He further states that, “The most important sources of prosperity are created not inherited. Productivity does not depend on what industries a region competes in, but on how it competes. The prosperity of a region depends on the productivity of all its industries.” Where, ideally, the ultimate goal is for Taiwan to gain momentum in supplying a pipeline to the US FDA Botanical Drug Path, efficiently and by an industry cluster. |
URI: | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/22706 |
全文授權: | 未授權 |
顯示於系所單位: | 商學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf 目前未授權公開取用 | 4.08 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。